|Daiichi Sankyo Company Limited -- USA Stock|| |
USD 22.25 0.11 0.5%
Executive Officer, Manager of Kyushu Office in Main Medical Sales of Japan CompanyWe currently do not have informatin regarding Ryoji Nagasaka. This executive tanure with Daiichi Sankyo Company Limited is not currenlty determined.
Executive Since 2016
81 3 6225 1111 http://www.daiichisankyo.com
The company has return on total asset (ROA)
of 2.71 %
which means that it generated profit of $2.71 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 3.89 %
meaning that it generated $3.89 on every $100 dollars invested by stockholders.
The company has accumulated 2.59 B in total debt with debt to equity ratio (D/E) of 23.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Daiichi Sankyo Company Limited has Current Ratio of 3.85 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Daiichi Sankyo Company, Limited engages in the research, development, manufacture, import, and marketing of pharmaceutical solutions worldwide. Daiichi Sankyo Company Limited (DSNKY) is traded on OTC Market in USA. It is located in Daiichi Sankyo Company, Limited, NihonbashihonchoTokyo, and employs 15,249 people.